As of 2026-09-13, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is 12.71 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.08 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is 211.5%.
The range of the Relative Valuation is 7.81 - 18.44 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 29.7x | 26.5x |
| Forward P/E multiples | 23.4x - 30.4x | 26.9x |
| Fair Price | 7.81 - 18.44 | 12.71 |
| Upside | 91.3% - 351.8% | 211.5% |
| Date | P/E |
| 2026-09-11 | 6.57 |
| 2026-09-10 | 6.40 |
| 2026-09-09 | 6.56 |
| 2026-09-08 | 6.72 |
| 2026-09-04 | 6.86 |
| 2026-09-03 | 6.91 |
| 2026-09-02 | 7.10 |
| 2026-09-01 | 6.88 |
| 2026-08-31 | 6.85 |
| 2026-08-28 | 6.65 |
| 2026-08-27 | 6.83 |
| 2026-08-26 | 6.91 |
| 2026-08-25 | 7.07 |
| 2026-08-24 | 6.65 |
| 2026-08-21 | 6.91 |
| 2026-08-20 | 6.67 |
| 2026-08-19 | 7.02 |
| 2026-08-18 | 6.94 |
| 2026-08-17 | 7.02 |
| 2026-08-14 | 6.94 |
| 2026-08-13 | 6.57 |
| 2026-08-12 | 6.96 |
| 2026-08-11 | 6.93 |
| 2026-08-10 | 6.52 |
| 2026-08-07 | 6.96 |
| 2026-08-06 | 6.86 |
| 2026-08-05 | 6.69 |
| 2026-08-04 | 6.94 |
| 2026-08-03 | 7.12 |
| 2026-07-31 | 6.81 |
| 2026-07-30 | 6.01 |
| 2026-07-29 | 5.74 |
| 2026-07-28 | 6.12 |
| 2026-07-27 | 6.30 |
| 2026-07-24 | 5.98 |
| 2026-07-23 | 6.11 |
| 2026-07-22 | 6.25 |
| 2026-07-21 | 6.30 |
| 2026-07-20 | 6.20 |
| 2026-07-17 | 6.22 |
| 2026-07-16 | 6.23 |
| 2026-07-15 | 6.44 |
| 2026-07-14 | 6.41 |
| 2026-07-13 | 6.78 |
| 2026-07-10 | 7.20 |
| 2026-07-09 | 7.52 |
| 2026-07-08 | 7.68 |
| 2026-07-07 | 7.20 |
| 2026-07-06 | 7.06 |
| 2026-07-02 | 6.98 |